Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

Related Keywords

Colorado ,United States ,Cincinnati ,Ohio ,Chicago ,Illinois ,American ,Jacqueline Garonzik Wang ,Lara Danziger Isakov ,Noelle Ebel ,Emily Henderson ,John Mcateer ,Emily Perito ,Olga Charnaya ,Scott Auerbach ,Saeed Mohammad ,Roberth Lurie ,Johns Hopkins ,Evelyn Hsu ,Teresa Chiang ,Ashley Thomas ,Caroline Qin ,Amy Feldman ,Johns Hopkins Children Center ,National Institute Of Allergy ,Johns Hopkins University School Of Medicine ,Cincinnati Children Hospital Medical Center ,Agency For Healthcare Research ,American Journal ,Johns Hopkins Medicine ,Johns Hopkins Children ,Johns Hopkins University School ,Hospital Colorado ,Cincinnati Children ,Hospital Medical Center ,Lucile Packard Children ,Hospital Stanford ,Seattle Children ,California San Francisco Benioff Children ,National Institute ,Infectious Diseases ,Healthcare Research ,Transplant ,Vaccine ,Allergy ,Antibodies ,Ntibody ,Children ,Hospital ,Immune Response ,Medicine ,Mh ,Pharmaceuticals ,Research ,Na ,Cars ,Ars Cov 2 ,Virus ,